Keywords: csl, submits, bla, fibrinogen, products, usa-based, behring

CSL submits BLA for fibrinogen products

Article | 28 July 2008

USA-based CSL Behring has submitted a Biologics License Application to the Food and Drug Administration requesting approval to market its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in